BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35997126)

  • 1. Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States.
    Lee YT; Singal AG; Lauzon M; Agopian VG; Luu M; Noureddin M; Todo T; Kim IK; Friedman ML; Kosari K; Nissen NN; Roberts LR; Heimbach JK; Gores GJ; Yang JD
    Cancer; 2022 Oct; 128(20):3610-3619. PubMed ID: 35997126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
    Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
    Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma.
    Sposito C; Ratti F; Cucchetti A; Ardito F; Ruzzenente A; Di Sandro S; Maspero M; Ercolani G; Di Benedetto F; Guglielmi A; Giuliante F; Aldrighetti L; Mazzaferro V
    J Hepatol; 2023 Feb; 78(2):356-363. PubMed ID: 36328332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma.
    Franssen S; Soares KC; Jolissaint JS; Tsilimigras DI; Buettner S; Alexandrescu S; Marques H; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Margonis GA; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Marsh JW; Cercek A; Kemeny N; Kingham TP; D'Angelica M; Pawlik TM; Jarnagin WR; Koerkamp BG
    JAMA Surg; 2022 Jul; 157(7):590-596. PubMed ID: 35544131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor size and survival in intrahepatic cholangiocarcinoma treated with surgical resection or ablation.
    Kanu EN; Rhodin KE; Masoud SJ; Eckhoff AM; Bartholomew AJ; Howell TC; Bao J; Befera NT; Kim CY; Blazer DG; Zani S; Nussbaum DP; Allen PJ; Lidsky ME
    J Surg Oncol; 2023 Dec; 128(8):1329-1339. PubMed ID: 37671594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study.
    Shaib YH; Davila JA; Henderson L; McGlynn KA; El-Serag HB
    J Clin Gastroenterol; 2007; 41(10):911-7. PubMed ID: 18090160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic Cholangiocarcinoma in the Liver Explant After Liver Transplantation: Histological Differentiation and Prognosis.
    Takahashi K; Obeid J; Burmeister CS; Bruno DA; Kazimi MM; Yoshida A; Abouljoud MS; Schnickel GT
    Ann Transplant; 2016 Apr; 21():208-15. PubMed ID: 27068242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis.
    Wang T; Kong J; Yang X; Shen S; Zhang M; Wang W
    J Surg Oncol; 2020 Mar; 121(3):524-537. PubMed ID: 31867746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Benefit Relative to Treatment Modalities Among Patients with Very Early Intrahepatic Cholangiocarcinoma: an Analysis of the National Cancer Database.
    Endo Y; Sasaki K; Munir MM; Woldesenbet S; Resende V; Rawicz-Pruszyński K; Waqar U; Mavani P; Katayama E; Yang J; Khalil M; Khan MMM; Kitago M; Pawlik TM
    J Gastrointest Surg; 2023 Oct; 27(10):2103-2113. PubMed ID: 37674099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A narrative review of intrahepatic cholangiocarcinoma: a surgical curative option.
    Melandro F; Nasto RA; Ginesini M; Balzano E; Bindi ML; Ghinolfi D; Lai Q
    Chin Clin Oncol; 2023 Apr; 12(2):13. PubMed ID: 37038053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and Causes of Death among Patients with Intrahepatic Cholangiocarcinoma in the United States from 2000 to 2018.
    Elgenidy A; Afifi AM; Jalal PK
    Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2169-2176. PubMed ID: 36099432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting very early recurrence in intrahepatic cholangiocarcinoma after curative hepatectomy using machine learning radiomics based on CECT: A multi-institutional study.
    Chen B; Mao Y; Li J; Zhao Z; Chen Q; Yu Y; Yang Y; Dong Y; Lin G; Yao J; Lu M; Wu L; Bo Z; Chen G; Xie X
    Comput Biol Med; 2023 Dec; 167():107612. PubMed ID: 37939408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Radiofrequency Ablation for Recurrent Intrahepatic Cholangiocarcinoma After Curative Resection: Multivariable Analysis of Factors Predicting Survival Outcomes.
    Chu HH; Kim JH; Shin YM; Won HJ; Kim PN
    AJR Am J Roentgenol; 2021 Aug; 217(2):426-432. PubMed ID: 34076458
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of the Affordable Care Act on Presentation, Treatment, and Outcomes of Intrahepatic Cholangiocarcinoma.
    Lima HA; Moazzam Z; Endo Y; Alaimo L; Diaz A; Woldesenbet S; Shaikh C; Munir MM; Azap LE; Yang J; Resende V; Pawlik TM
    J Gastrointest Surg; 2023 Feb; 27(2):262-272. PubMed ID: 36400904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?
    Sapisochin G; Rodríguez de Lope C; Gastaca M; Ortiz de Urbina J; Suarez MA; Santoyo J; Castroagudín JF; Varo E; López-Andujar R; Palacios F; Sanchez Antolín G; Perez B; Guiberteau A; Blanco G; González-Diéguez ML; Rodriguez M; Varona MA; Barrera MA; Fundora Y; Ferron JA; Ramos E; Fabregat J; Ciria R; Rufian S; Otero A; Vazquez MA; Pons JA; Parrilla P; Zozaya G; Herrero JI; Charco R; Bruix J
    Am J Transplant; 2014 Mar; 14(3):660-7. PubMed ID: 24410861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014.
    Antwi SO; Mousa OY; Patel T
    Ann Hepatol; 2018 July - August ,; 17(4):604-614. PubMed ID: 29893702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis.
    Merath K; Mehta R; Hyer JM; Bagante F; Sahara K; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Ejaz A; Pawlik TM
    Eur J Surg Oncol; 2019 Jun; 45(6):1084-1091. PubMed ID: 30871884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials.
    Lamarca A; Ross P; Wasan HS; Hubner RA; McNamara MG; Lopes A; Manoharan P; Palmer D; Bridgewater J; Valle JW
    J Natl Cancer Inst; 2020 Feb; 112(2):200-210. PubMed ID: 31077311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.